Mark Lerner
Director/Board Member at Gliknik, Inc.
Profile
Mark David Lerner is the founder of Chesapeake Partners Management Co., Inc. which was founded in 1991.
He held the title of Vice President.
Currently, he is a Non-Executive Director at Gliknik, Inc. since 2014.
Mr. Lerner has an undergraduate degree from the University of Pennsylvania and The Wharton School of the University of Pennsylvania.
Mark Lerner active positions
| Companies | Position | Start |
|---|---|---|
Gliknik, Inc.
 Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | Director/Board Member | 2014-02-18 |
Former positions of Mark Lerner
| Companies | Position | End |
|---|---|---|
Chesapeake Partners Management Co., Inc.
 Chesapeake Partners Management Co., Inc. Investment ManagersFinance Founded in 1991, Chesapeake Partners Management Co., Inc. is a hedge fund manager located in Baltimore, Maryland. The firm manages the Chesapeake Partners Funds. Investors in the funds include high net-worth individuals and families; pension and profit-sharing plans; trusts, estates or charitable or religious organizations and other corporations or business entities. | Founder | - |
Training of Mark Lerner
| University of Pennsylvania | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Chesapeake Partners Management Co., Inc.
Chesapeake Partners Management Co., Inc. Investment ManagersFinance Founded in 1991, Chesapeake Partners Management Co., Inc. is a hedge fund manager located in Baltimore, Maryland. The firm manages the Chesapeake Partners Funds. Investors in the funds include high net-worth individuals and families; pension and profit-sharing plans; trusts, estates or charitable or religious organizations and other corporations or business entities. | Finance |
Gliknik, Inc.
Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | Health Technology |
- Stock Market
- Insiders
- Mark Lerner
